Overview
Howard Greenberg is a Hematologist in Greenlawn, New York. Dr. Greenberg is rated as an Advanced provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Myelodysplastic Syndrome (MDS), Thrombocytopenia, Idiopathic Neutropenia, and Essential Thrombocythemia.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5 Cuba Hill Rd, Greenlawn, NY 11740
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Icahn School Of Medicine At Mount Sinai
Kevin Troy is a Hematologist in New York, New York. Dr. Troy is rated as a Distinguished provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Factor 11 Deficiency, Thrombocytopenia, Idiopathic Neutropenia, Shwartzman Phenomenon, and Bone Marrow Aspiration.
Memorial Hematology Lymphoma Group
Hani Hassoun is a Hematologist and an Oncologist in New York, New York. Dr. Hassoun is rated as an Elite provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
New York University
Bruce Raphael is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Raphael is rated as a Distinguished provider by MediFind in the treatment of POEMS Syndrome. His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Myelodysplastic Syndrome (MDS)Dr. Greenberg isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Adult Immune ThrombocytopeniaDr. Greenberg isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Greenberg isAdvanced. Learn about Agranulocytosis.
- Alpha ThalassemiaDr. Greenberg isAdvanced. Learn about Alpha Thalassemia.
- Alpha Thalassemia X-Linked Intellectual Disability Syndrome
- AnemiaDr. Greenberg isAdvanced. Learn about Anemia.
- B-Cell LymphomaDr. Greenberg isAdvanced. Learn about B-Cell Lymphoma.
- Experienced
- Acquired AgranulocytosisDr. Greenberg isExperienced. Learn about Acquired Agranulocytosis.
- Acute Eosinophilic PneumoniaDr. Greenberg isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Myeloblastic Leukemia with MaturationDr. Greenberg isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Greenberg isExperienced. Learn about Acute Myeloid Leukemia (AML).
- ALK-Positive Non-Small Cell Lung CancerDr. Greenberg isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.